79 results
Page 3 of 4
S-3
vx9be
4 Feb 22
Shelf registration
4:36pm
8-K
EX-99.1
fr6ohx rw
19 Jan 22
InMed Launches Cannabicitran (CBT), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector
4:09pm
8-K
EX-99.1
w98s2yaz5
5 Jan 22
InMed Issues Annual Letter to Shareholders Highlighting Key Accomplishments from 2021 and Providing 2022 Outlook
2:22pm
8-K
EX-2.1
6cea6t
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
EX-2.1
2aaklb
24 Sep 21
Annual report
7:31am
10-K
3jvrn
24 Sep 21
Annual report
7:31am
424B3
ka5 xyr84
22 Jul 21
Prospectus supplement
10:27am
8-K
EX-99.1
hpehnfdmwsdrc9bj3
29 Jun 21
InMed Pharmaceuticals Signs Non-binding Letter of Intent to Acquire BayMedica, a Commercial Manufacturer of Rare Cannabinoids
3:12pm
424B3
8yyzs3 xc0
16 Mar 21
Prospectus supplement
12:00am
424B4
92ap1 tvs80u8d7f
13 Nov 20
Prospectus supplement with pricing info
8:52pm